Acquisition of fetal bovine serum
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201700699P
- Awardee
-
Atlanta Biologicals, Inc. UEI ULFTKRGFBBA5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $33,495
Award facts
- Opportunity
-
- NO2RC7271136A Solicitation number
- Contract value 100% obligated
- $33,494.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 5 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Flowery Branch, GA, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Atlanta Biologicals, Inc. for $33,494.70 on September 18, 2017, to acquire fetal bovine serum. Performance is scheduled to conclude by October 19, 2017, and will take place in Flowery Branch, Georgia. The order is priced on a firm fixed price basis with no small business set-aside.
Quick answers
Who was awarded contract HHSN261201700699P?
HHSN261201700699P was awarded to Atlanta Biologicals, Inc. by National Cancer Institute (National Institutes of Health) on September 18, 2017.
How much is contract HHSN261201700699P worth?
The government has obligated $33,495 on HHSN261201700699P.
Was contract HHSN261201700699P competed?
The extent of competition for HHSN261201700699P was competed under sap. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award